ANIMATION

EGFRvIII(+) Glioblastoma

Share this animation:

Glioblastoma multiforme is considered one of the most aggressive cancers, with an estimated 5-year survival rate of less than 5%. It has been found that approximately 30% of glioblastoma tumors selectively express the EGFRvIII variant receptor, the activity of which contributes to tumor growth, resistance to apoptosis, and tumor angiogenesis. The persistence of EGFRvIII on glioblastoma cells suggest it may be a viable candidate for more targeted therapeutic approaches.

Share It:
Contact XVIVO

Client


Celldex

The feedback from the client was all very positive. I want to thank the XVIVO team for a job well done. Our work with the client’s clinical team up front paid off on the back end with minimal revisions and I want to thank you guys for your patience and hard work.

Vice President | Creative Director, The Navicor Group, LLC
Share this animation: